A detailed history of South Dakota Investment Council transactions in Haemonetics Corp stock. As of the latest transaction made, South Dakota Investment Council holds 23,246 shares of HAE stock, worth $2.05 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
23,246
Previous 23,246 -0.0%
Holding current value
$2.05 Million
Previous $1.92 Million 2.81%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$81.24 - $97.37 $2,437 - $2,921
-30 Reduced 0.13%
23,246 $1.92 Million
Q1 2024

May 02, 2024

SELL
$71.24 - $85.35 $99,736 - $119,489
-1,400 Reduced 5.67%
23,276 $1.99 Million
Q3 2023

Nov 07, 2023

SELL
$82.56 - $93.49 $16,512 - $18,698
-200 Reduced 0.8%
24,676 $2.21 Million
Q2 2023

Aug 10, 2023

SELL
$80.84 - $89.45 $129,344 - $143,120
-1,600 Reduced 6.04%
24,876 $2.12 Million
Q4 2022

Feb 07, 2023

BUY
$73.85 - $86.14 $51,399 - $59,953
696 Added 2.7%
26,476 $2.08 Million
Q3 2022

Nov 09, 2022

BUY
$63.3 - $78.66 $398,790 - $495,558
6,300 Added 32.34%
25,780 $1.91 Million
Q1 2022

May 10, 2022

SELL
$43.77 - $63.22 $350,160 - $505,760
-8,000 Reduced 29.11%
19,480 $1.23 Million
Q2 2021

Aug 11, 2021

BUY
$51.81 - $118.56 $549,186 - $1.26 Million
10,600 Added 62.8%
27,480 $1.83 Million
Q1 2021

May 13, 2021

BUY
$111.01 - $139.48 $108,789 - $136,690
980 Added 6.16%
16,880 $1.87 Million
Q4 2020

Feb 12, 2021

BUY
$88.75 - $119.95 $150,875 - $203,915
1,700 Added 11.97%
15,900 $1.89 Million
Q3 2020

Nov 06, 2020

BUY
$75.65 - $93.58 $295,035 - $364,962
3,900 Added 37.86%
14,200 $1.24 Million
Q2 2020

Aug 13, 2020

BUY
$84.96 - $118.91 $416,303 - $582,659
4,900 Added 90.74%
10,300 $922,000
Q1 2020

May 11, 2020

BUY
$74.34 - $121.82 $401,436 - $657,828
5,400 New
5,400 $538,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.52B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track South Dakota Investment Council Portfolio

Follow South Dakota Investment Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.